Research advances on extensive-drug resistant Acinetobacter baumannii
Haifang Kong
Abstract
Haifang Kong
Abstract
With the wide application of antibiotics, Acinetobacter baumannii infection has increased gradually. The clinical isolating rates of multidrug resistant (MDR) , extensive-drug resistant (XDR) and even pan-drug resistant (PDR) A. baumannii increase significantly. A. baumannii has become an important opportunistic pathogen in the nosocomial setting. The article reviews the resistance mechanism and therapeutic options of the extensive-drug resistant A. Baumannii. Key words: Acinetobacter baumannii; Extensive-drug resistance; Resistance mechanism; Therapeutic options
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
With the wide application of antibiotics, Acinetobacter baumannii infection has increased gradually. The clinical isolating rates of multidrug resistant (MDR) , extensive-drug resistant (XDR) and even pan-drug resistant (PDR) A. baumannii increase significantly. A. baumannii has become an important opportunistic pathogen in the nosocomial setting. The article reviews the resistance mechanism and therapeutic options of the extensive-drug resistant A. Baumannii. Key words: Acinetobacter baumannii; Extensive-drug resistance; Resistance mechanism; Therapeutic options
Key concepts: Acinetobacter baumannii, Drug resistance, Drug, Multiple drug resistance, Microbiology, Multi drug resistant, Antibiotics, Biology